• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚胺 2,3-双加氧酶 2 耗竭抑制 Lewis 肺癌小鼠模型中的肿瘤生长。

Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.

机构信息

Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.

Graduate School of Health Sciences, Advanced Diagnostic System Research Laboratory, Fujita Health University, Toyoake, Japan.

出版信息

Cancer Sci. 2019 Oct;110(10):3061-3067. doi: 10.1111/cas.14179. Epub 2019 Sep 25.

DOI:10.1111/cas.14179
PMID:31444833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6778659/
Abstract

Tryptophan metabolism is important to induce immune tolerance in tumors. To date, 3 types of tryptophan-metabolizing enzymes have been identified: indoleamine 2,3-dioxygenase 1 and 2 (IDO1 and IDO2) and tryptophan 2,3-dioxygenase 2. Numerous studies have focused on IDO1 as its expression is enhanced in various cancers. Recently, IDO2 has been identified as a tryptophan-metabolizing enzyme that is involved in several immune functions and expressed in cancers such as pancreatic cancer. However, the biological role of IDO2 in the induction of immune tolerance in tumors has not yet been reported. In the present study, we examined the effects of Ido2 depletion on tumor growth in a mouse model of Lewis lung carcinoma by using Ido2-knockout mice. Ido2-knockout mice had reduced tumor volumes compared to WT mice. Furthermore, Ido2 depletion altered the tumor microenvironment, such as tryptophan accumulation and kynurenine reduction, leading to enhancement of immune cell invasion. Finally, enzyme-linked immunospot assay revealed that Ido2 depletion enhanced γ-interferon secretion in the tumor. In conclusion, Ido2 is an important immune regulator in the tumor microenvironment. Our data indicate that IDO2 is a potential target for cancer treatment and drug development.

摘要

色氨酸代谢对于诱导肿瘤中的免疫耐受很重要。迄今为止,已经鉴定出 3 种色氨酸代谢酶:吲哚胺 2,3-双加氧酶 1 和 2(IDO1 和 IDO2)和色氨酸 2,3-双加氧酶 2。许多研究都集中在 IDO1 上,因为它在各种癌症中的表达增强。最近,IDO2 被鉴定为一种参与多种免疫功能的色氨酸代谢酶,并在胰腺癌等癌症中表达。然而,IDO2 在诱导肿瘤免疫耐受中的生物学作用尚未报道。在本研究中,我们通过使用 IDO2 敲除小鼠来检查 Ido2 耗竭对 Lewis 肺癌小鼠模型中肿瘤生长的影响。与 WT 小鼠相比,IDO2 敲除小鼠的肿瘤体积减小。此外,IDO2 耗竭改变了肿瘤微环境,例如色氨酸积累和犬尿氨酸减少,导致免疫细胞浸润增强。最后,酶联免疫斑点分析显示,IDO2 耗竭增强了肿瘤中的γ-干扰素分泌。总之,IDO2 是肿瘤微环境中的重要免疫调节剂。我们的数据表明,IDO2 是癌症治疗和药物开发的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/46f7680dbc5b/CAS-110-3061-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/f65982ac7495/CAS-110-3061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/611f8852049b/CAS-110-3061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/2aa5d6f95ca3/CAS-110-3061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/46f7680dbc5b/CAS-110-3061-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/f65982ac7495/CAS-110-3061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/611f8852049b/CAS-110-3061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/2aa5d6f95ca3/CAS-110-3061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c963/6778659/46f7680dbc5b/CAS-110-3061-g004.jpg

相似文献

1
Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.吲哚胺 2,3-双加氧酶 2 耗竭抑制 Lewis 肺癌小鼠模型中的肿瘤生长。
Cancer Sci. 2019 Oct;110(10):3061-3067. doi: 10.1111/cas.14179. Epub 2019 Sep 25.
2
Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity.通过干扰素γ基因转移上调吲哚胺2,3-双加氧酶1对干扰素γ介导的抗肿瘤活性的影响。
Gene Ther. 2014 Sep;21(9):794-801. doi: 10.1038/gt.2014.54. Epub 2014 Jun 12.
3
Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model.沉默树突状细胞中的 IDO2:一种增强小鼠肺癌模型中癌症免疫治疗的新策略。
Int J Oncol. 2020 Aug;57(2):587-597. doi: 10.3892/ijo.2020.5073. Epub 2020 May 26.
4
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.吲哚胺2,3-双加氧酶-2;犬尿氨酸途径中的一种新酶。
Int J Biochem Cell Biol. 2009 Mar;41(3):467-71. doi: 10.1016/j.biocel.2008.01.005. Epub 2008 Jan 11.
5
Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.吲哚胺 2,3-双加氧酶 2 产生的犬尿氨酸通过加剧四氯化碳诱导的小鼠急性肝损伤。
Toxicology. 2020 May 30;438:152458. doi: 10.1016/j.tox.2020.152458. Epub 2020 Apr 11.
6
Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.吲哚胺 2,3-双加氧酶 1:恶性肿瘤治疗的新靶点
Front Immunol. 2021 Dec 23;12:800630. doi: 10.3389/fimmu.2021.800630. eCollection 2021.
7
Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1.人吲哚胺2,3-双加氧酶-2具有与吲哚胺2,3-双加氧酶-1不同的底物特异性和抑制特性。
Amino Acids. 2014 Sep;46(9):2155-63. doi: 10.1007/s00726-014-1766-3. Epub 2014 May 30.
8
Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.TDO2、IDO-1和IDO-2的缺失对小鼠行为和认知功能有不同影响。
Behav Brain Res. 2016 Oct 1;312:102-17. doi: 10.1016/j.bbr.2016.06.018. Epub 2016 Jun 15.
9
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.吲哚胺2,3-双加氧酶1(IDO1)和吲哚胺2,3-双加氧酶2(IDO2)在人类肿瘤中表达:左旋而非右旋1-甲基色氨酸抑制色氨酸分解代谢。
Cancer Immunol Immunother. 2009 Jan;58(1):153-7. doi: 10.1007/s00262-008-0513-6. Epub 2008 Apr 17.
10
Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease.色氨酸 2,3-双加氧酶 2(IDO2)和犬尿氨酸途径:在健康和疾病中的特征和潜在作用。
Amino Acids. 2013 Dec;45(6):1319-29. doi: 10.1007/s00726-013-1602-1. Epub 2013 Oct 9.

引用本文的文献

1
Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation.肿瘤微环境驱动的非小细胞肺癌免疫治疗耐药性:冷肿瘤向热肿瘤转变的策略
Cancer Drug Resist. 2025 Apr 24;8:21. doi: 10.20517/cdr.2025.14. eCollection 2025.
2
Promising Gastric Cancer Biomarkers-Focus on Tryptophan Metabolism via the Kynurenine Pathway.有前景的胃癌生物标志物——聚焦于通过犬尿氨酸途径的色氨酸代谢
Int J Mol Sci. 2025 Apr 14;26(8):3706. doi: 10.3390/ijms26083706.
3
The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2).

本文引用的文献

1
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.高 IDO1 表达与接受根治性放化疗的肛门癌患者的不良预后相关。
Oncologist. 2019 Jun;24(6):e275-e283. doi: 10.1634/theoncologist.2018-0794. Epub 2019 Feb 12.
2
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
3
Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.
吲哚胺 2,3-双加氧酶 2(IDO2)的两面性。
Cells. 2024 Nov 16;13(22):1894. doi: 10.3390/cells13221894.
4
The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer.犬尿氨酸途径在癌症中呈现出多方面的代谢脆弱性。
Front Oncol. 2023 Oct 9;13:1256769. doi: 10.3389/fonc.2023.1256769. eCollection 2023.
5
Development of a DNA aptamer targeting IDO1 with anti-tumor effects.一种具有抗肿瘤作用的靶向吲哚胺2,3-双加氧酶1(IDO1)的DNA适配体的研发。
iScience. 2023 Jul 13;26(8):107367. doi: 10.1016/j.isci.2023.107367. eCollection 2023 Aug 18.
6
Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer.芳香烃受体(AhR)对乳腺癌中 IDO2 的调控。
Cells. 2023 May 20;12(10):1433. doi: 10.3390/cells12101433.
7
Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation-Cancer Interface.吲哚胺2,3-双加氧酶(IDO)和犬尿氨酸途径在炎症-癌症界面与细胞转导系统及代谢的相互作用。
Cancers (Basel). 2023 May 24;15(11):2895. doi: 10.3390/cancers15112895.
8
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer.吲哚胺2,3-双加氧酶1/色氨酸2,3-双加氧酶2的双重抑制增强铂耐药非小细胞肺癌的抗肿瘤免疫。
Cancer Metab. 2023 May 24;11(1):7. doi: 10.1186/s40170-023-00307-1.
9
Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.吲哚胺-2,3 双加氧酶:肿瘤微环境的命运改变者。
Mol Biol Rep. 2023 Jul;50(7):6133-6145. doi: 10.1007/s11033-023-08469-3. Epub 2023 May 22.
10
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.吲哚胺 2,3-双加氧酶 2 在甲状腺髓样癌中的免疫组化表达:对预后的影响及免疫调节作用。
BMC Cancer. 2022 Nov 1;22(1):1116. doi: 10.1186/s12885-022-10173-7.
二芳基羟胺作为吲哚胺 2,3-双加氧酶-1、吲哚胺 2,3-双加氧酶-2 和色氨酸双加氧酶的泛或双重抑制剂。
Eur J Med Chem. 2019 Jan 15;162:455-464. doi: 10.1016/j.ejmech.2018.11.010. Epub 2018 Nov 14.
4
Host Gene Status Influences Tumor Progression and Radiotherapy Response in -Driven Sporadic Pancreatic Cancers.宿主基因状态影响 - 驱动的散发性胰腺肿瘤的肿瘤进展和放疗反应。
Clin Cancer Res. 2019 Jan 15;25(2):724-734. doi: 10.1158/1078-0432.CCR-18-0814. Epub 2018 Sep 28.
5
Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.肝癌中吲哚胺 2,3-双加氧酶 1 的表达机制及其预后价值。
Cancer Sci. 2018 Dec;109(12):3726-3736. doi: 10.1111/cas.13811. Epub 2018 Nov 5.
6
Pillars Article: IFNγ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. . 2001. 410: 1107-1111.支柱文章:干扰素γ和淋巴细胞可预防原发性肿瘤的发生并塑造肿瘤免疫原性。. 2001年。410: 1107 - 1111。
J Immunol. 2018 Aug 1;201(3):827-831.
7
Migrating into the Tumor: a Roadmap for T Cells.迁移至肿瘤:T细胞的路线图
Trends Cancer. 2017 Nov;3(11):797-808. doi: 10.1016/j.trecan.2017.09.006. Epub 2017 Nov 6.
8
IDO1: An important immunotherapy target in cancer treatment.吲哚胺 2,3-双加氧酶 1:癌症治疗中的一个重要免疫治疗靶点。
Int Immunopharmacol. 2017 Jun;47:70-77. doi: 10.1016/j.intimp.2017.03.024. Epub 2017 Mar 30.
9
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.肿瘤发生过程中对γ干扰素依赖性免疫监视的逃逸。
J Biomed Sci. 2017 Feb 1;24(1):10. doi: 10.1186/s12929-017-0317-0.
10
Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency.中性粒细胞在吲哚胺2,3-双加氧酶短发夹RNA介导的抗肿瘤效率中至关重要。
Mol Ther Nucleic Acids. 2016 Dec 6;5(12):e397. doi: 10.1038/mtna.2016.105.